GlassScriptPhysician profile
Michael N Hitsman
NPI 1306387907
$2,976.89
in general payments reported to CMS, 2019-2025
25 companies · $18.89 in 2025
The $18.89 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $285 · 2020: $396 · 2021: $1,201 · 2022: $637 · 2023: $438 · 2025: $18.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $457.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $456.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $431.33 | 2019-2023 | |
| Glaxosmithkline, LLC. | $338.04 | 2020-2023 | Trelegy Ellipta, Shingrix, Arexvy |
| Pfizer INC. | $235.22 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $232.71 | 2020-2023 | Farxiga |
| Janssen Pharmaceuticals, INC | $225.37 | 2021-2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $224.25 | 2020-2022 | |
| Amgen INC. | $213.57 | 2019-2023 | Evenity, Prolia |
| Lilly USA, LLC | $144.12 | 2020-2023 | Mounjaro |
| Takeda Pharmaceuticals U.S.A., INC. | $132.61 | 2020-2023 | Trintellix |
| Bayer Healthcare Pharmaceuticals INC. | $117.96 | 2021-2023 | |
| Novartis Pharmaceuticals Corporation | $87.50 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $83.36 | 2020-2022 | |
| Novo Nordisk INC | $80.27 | 2020-2023 | Ozempic, Rybelsus |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $76.76 | 2020-2022 | |
| Amarin Pharma, INC. | $62.35 | 2020-2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $56.53 | 2020-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $52.66 | 2020 | |
| Exact Sciences Corporation | $39.81 | 2023 | Cologuard Collection Kit |
| Biogen, INC. | $34.93 | 2021-2022 | |
| Allergan, INC. | $28.76 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $17.93 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $16.85 | 2022 | |
| Paratek Pharmaceuticals, INC. | $15.56 | 2023 | Nuzyra |
| Genentech USA, INC. | $14.72 | 2021 | |
| Sanofi-Aventis U.S. LLC | $13.72 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Hitsman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.